R

Response Oncology Inc
OTC:ROIX

Watchlist Manager
Response Oncology Inc
OTC:ROIX
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $12

Response Oncology Inc
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Response Oncology Inc
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
R
Response Oncology Inc
OTC:ROIX
Other
-$146k
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
1%
Universal Health Services Inc
NYSE:UHS
Other
$10.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tenet Healthcare Corp
NYSE:THC
Other
-$919m
CAGR 3-Years
-9%
CAGR 5-Years
-41%
CAGR 10-Years
-8%
HCA Healthcare Inc
NYSE:HCA
Other
-$1.1B
CAGR 3-Years
5%
CAGR 5-Years
-5%
CAGR 10-Years
-12%
MEDNAX Inc
NYSE:MD
Other
-$3.2m
CAGR 3-Years
N/A
CAGR 5-Years
-17%
CAGR 10-Years
19%
iRhythm Technologies Inc
NASDAQ:IRTC
Other
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Response Oncology Inc
Glance View

Market Cap
12 USD
Industry
N/A

Response Oncology, Inc. engages in the provision of cancer treatment services through outpatient facilities known as IMPACT centers. The company is headquartered in Memphis, Tennessee and currently employs 10 full-time employees. As of May 20, 2002, the Company had liquidated substantially all of its operating assets and anticipates that the remaining assets will be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, the Company provided advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the non-medical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers.

ROIX Intrinsic Value
Not Available
R

See Also

What is Response Oncology Inc's Other?
Other
-146k USD

Based on the financial report for Mar 31, 2002, Response Oncology Inc's Other amounts to -146k USD.

What is Response Oncology Inc's Other growth rate?
Other CAGR 10Y
1%

Over the last year, the Other growth was 88%. The average annual Other growth rates for Response Oncology Inc have been 23% over the past three years , and 1% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett